FABIAN 2008

Door de sprekers beschikbaar gestelde PDF rendities van de presentaties.

Slides	Presentation
Abstract
	Biosimilars or why proteins cannot be copied Vera Brinks Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht, the Netherlands	08L01
	Comparability Assessment Strategies and Techniques for Post-Approval CMC Changes Reed Harris Protein Analytical Chemistry, Genentech Inc. South San Francisco, CA, USA	08L02
< not available >	Development of Biosimilars: Binocrit® - the worlds first biosimilar ESA as a case study Andreas Seidl, Uwe Demelbauer, Carsten Brockmeyer Sandoz Biopharmaceutical Development, Hexal AG, Oberhaching, Germany	08L03
	Analytical assessment of biotech product quality Robert van den Heuvel Schering-Plough, Oss	08L04
< not available >	Oral recombinant enzyme replacement therapy: DMPK and Immunogenicity Assessment (A Case Study) Claudia Berger Solvay Pharmaceuticals, Hanover, Germany SPEAKER ILL: WITHDRAWN	08L05
	THE CHALLENGES OF “LARGE MOLECULE” LIGAND-BINDING ASSAYS - VALIDATION AND BIOANALYSIS Joseph Marini Centocor, Radnor, PA, USA	08L06
	Immunogenicity considerations for biologics Meena Subramanyan Biogen Idec, Cambridge, MA, USA	08L07

* Contact

[ Programma ] [ Abstracts ] [ Posters ] [ Submissie ] [ Slides ] [ Hotels ] [ Route ]
[ 2001 ] [ 2002 ] [ 2003 ] [ 2004 ] [ 2005 ] [ 2006 ] [ 2007 ] [ 2008 ] [ 2009 ]

Last update
27-Oct-09